Video: Vital drug elude HIV victims

Zimbabwean HIV victims cannot afford to buy drugs that slow progression of Aids.

Shortage of vital drugs puts HIV sufferers at further risk

In the first of a series on the stigma of HIV and Aids, Al Jazeera visits Zimbabwe where HIV patients face a shortage of anti-retroviral drugs.

The treatment is essential because it slows the progression of HIV to Aids.

The Global Fund has provided a $37 million donation but health officials say it is not enough.

Al Jazeera’s Haru Mutasa reports from Bulawayo in Zimbabwe.